TITLE:
Study of Milnacipran for the Treatment of Fibromyalgia

CONDITION:
Fibromyalgia

INTERVENTION:
milnacipran hydrochloride

SUMMARY:

      Antidepressants of all varieties represent a common form of therapy for many chronic states
      including fibromyalgia. The majority of antidepressants increase the levels of serotonin or
      norepinephrine in the central nervous system. Milnacipran is a dual norepinephrine and
      serotonin reuptake inhibitor and may be effective in the treatment of fibromyalgia.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to 70 Years
Criteria:

        Inclusion Criteria:

          -  Diagnosis of fibromyalgia defined by 1990 American College of Rheumatology (ACR)
             Criteria

        Exclusion Criteria:

          -  Psychiatric illness

          -  Depression

          -  Suicidal risk

          -  Substance abuse

          -  Pulmonary dysfunction

          -  Renal impairment

          -  Active cardiac disease

          -  Liver disease

          -  Autoimmune disease

          -  Cancer

          -  Sleep apnea

          -  Inflammatory bowel disease
      
